First Time Loading...
J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 859 JPY 0.35%
Updated: Mar 29, 2024

Intrinsic Value

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. [ Read More ]

The intrinsic value of one JCR Pharmaceuticals Co Ltd stock under the Base Case scenario is 1 609.08 JPY. Compared to the current market price of 859 JPY, JCR Pharmaceuticals Co Ltd is Undervalued by 47%.

Key Points:
Intrinsic Value
Base Case
1 609.08 JPY
Undervaluation 47%
Intrinsic Value
Price
J
Worst Case
Base Case
Best Case

Valuation Backtest
JCR Pharmaceuticals Co Ltd

Backtest JCR Pharmaceuticals Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling JCR Pharmaceuticals Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
JCR Pharmaceuticals Co Ltd

Current Assets 57.5B
Cash & Short-Term Investments 18.3B
Receivables 16.3B
Other Current Assets 22.9B
Non-Current Assets 45.3B
Long-Term Investments 9.3B
PP&E 30.7B
Intangibles 3.6B
Other Non-Current Assets 1.8B
Current Liabilities 31.9B
Accounts Payable 1.6B
Accrued Liabilities 607m
Other Current Liabilities 29.7B
Non-Current Liabilities 15.2B
Long-Term Debt 13.6B
Other Non-Current Liabilities 1.6B
Efficiency

Earnings Waterfall
JCR Pharmaceuticals Co Ltd

Revenue
41.4B JPY
Cost of Revenue
-10.4B JPY
Gross Profit
31B JPY
Operating Expenses
-23.1B JPY
Operating Income
7.8B JPY
Other Expenses
-2.5B JPY
Net Income
5.4B JPY

Free Cash Flow Analysis
JCR Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

JCR Pharmaceuticals Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
Positive 3-Years Revenue Growth
56/100
Profitability
Score

JCR Pharmaceuticals Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

JCR Pharmaceuticals Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
High Altman Z-Score
76/100
Solvency
Score

JCR Pharmaceuticals Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
JCR Pharmaceuticals Co Ltd

Wall Street analysts forecast JCR Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 1 823.25 JPY with a low forecast of 1 212 JPY and a high forecast of 2 835 JPY.

Lowest
Price Target
1 212 JPY
41% Upside
Average
Price Target
1 823.25 JPY
112% Upside
Highest
Price Target
2 835 JPY
230% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
JCR Pharmaceuticals Co Ltd

1M 1M
-5%
6M 6M
-43%
1Y 1Y
-44%
3Y 3Y
-75%
5Y 5Y
-47%
10Y 10Y
+52%
Annual Price Range
859
52w Low
856
52w High
1 534
Price Metrics
Average Annual Return 2.3%
Standard Deviation of Annual Returns 26.57%
Max Drawdown -77%
Shares Statistics
Market Capitalization 107.2B JPY
Shares Outstanding 124 776 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

JCR Pharmaceuticals Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

107.2B JPY

Dividend Yield

2.34%

Description

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ashiya-Shi, Hyogo-Ken and currently employs 732 full-time employees. The firm operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.

Contact

HYOGO-KEN
Ashiya-shi
3-19, Kasuga-cho
+81797328591.0
http://www.jcrpharm.co.jp/

IPO

1995-03-16

Employees

732

Officers

Chairman, CEO & President
Mr. Shin Ashida
Director of Accounting Department & Corporate Strategy Department (Finance)
Yoshihiro Ota
Sr. Corp. Officer, Exec. Director of Admin Div. and Director of General Affairs & HR Planning Dept.
Yutaka Honda
Director of Legal Affairs Department - Administration Division
Hiroyuki Fukuya
Senior VP of Sales & Administration, Executive Director of Sales Division and Director
Toru Ashida
Director of Marketing Dept. & Group Manager of Product Planning - Marketing Dept. for Sales Div.
Ryutaro Makino
Show More
Executive Vice President
Katsuya Nishino
Senior Advisor
Hiroshi Yoshimoto
Corporate Officer & Director of International Affairs Office
Takayo Egawa
VP of Research & Corporate Strategy, Executive Director of Research Division and Director
Mr. Hiroyuki Sonoda Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one JCR Pharmaceuticals Co Ltd stock?

The intrinsic value of one JCR Pharmaceuticals Co Ltd stock under the Base Case scenario is 1 609.08 JPY.

Is JCR Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 859 JPY, JCR Pharmaceuticals Co Ltd is Undervalued by 47%.